Articles

Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia

Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen; Institute for Clinical Transfusion Medicine, University Hospital of Tuebingen
Institute for Pathology, University Hospital of Ulm
Institute for Clinical Transfusion Medicine, University Hospital of Tuebingen
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen
Institute for Pathology, University Hospital of Ulm
Department of Neurosurgery, Krankenhaus der Barmherzigen Brüder Trier, Trier
Institute for Pathology and Neuropathology, University Hospital of Tuebingen
Department of Internal Medicine IV, Section of Nephrology and Hypertension, University Hospital of Tuebingen
Department of Neuroradiology, University Hospital Bonn
Division of Vascular Neurology, University Hospital Bonn
Department of Neuroradiology, Klinikum Stuttgart, Stuttgart
Department of Internal Medicine IV, Section of Nephrology and Hypertension, University Hospital of Tuebingen
Institute for Immunology, University Hospital of Ulm
Institute for Pathology, University Hospital of Ulm
Department of Neurology, Krankenhaus der Barmherzigen Brüder Trier, Trier
Institute of Transfusion Medicine, Klinikum Stuttgart, Stuttgart
Department of Neurology, Krankenhaus der Barmherzigen Brüder Trier, Trier
Institute of Molecular Virology, Ulm University Medical Center, Ulm
Institute of Molecular Virology, Ulm University Medical Center, Ulm
Department of Neurology, University Hospital Heidelberg
Institute for Experimental Hematology and Transfusion Medicine, Bonn
Institute for Experimental Hematology and Transfusion Medicine, Bonn
University Hospital of Ulm
Internal Medicine III, University Hospital of Ulm
Department of Neurology, Klinikum Stuttgart, Stuttgart
Department of Neurology, Klinikum Stuttgart, Stuttgart
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen
Institute for Pathology and Neuropathology, University Hospital of Tuebingen
Department of Radiology, Krankenhaus der Barmherzigen Brüder Trier, Trier
Anaesthesiology and Intensive Care Medicine, University Hospital Tuebingen
Natural and Medical Sciences Institute, University of Tuebingen, Reutlingen
Department of Neurology, University Hospital Heidelberg
Department of Thrombosis and Hemostasis and Institute of Immunology and Transfusion Medicine, Giessen
Institute for Pathology and Neuropathology, University Hospital of Tuebingen
Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen; Institute for Clinical Transfusion Medicine, University Hospital of Tuebingen
Vol. 106 No. 8 (2021): August, 2021 https://doi.org/10.3324/haematol.2021.279000